• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
UNQUOTE
  • DACH

Sofinnova-backed Auris announces price range

  • Harriet Bailey
  • Harriet Bailey
  • 23 July 2014
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Auris Medical, a Switzerland-based biotech company backed by Sofinnova Partners and Sofinnova Ventures, has announced the terms for its IPO.

Auris is offering 6.9 million common shares, with the option to purchase an additional 1.04 million shares. The estimated price range is $10-12 per share, resulting in a $69-82m flotation.

It has applied to list on the Nasdaq Global Select Market under the ticker symbol "EARS".

Jefferies and Leerink Partners are acting as joint bookrunners, while JMP Securities and Needham & Co are acting as co-managers.

Sofinnova Ventures currently has a 19.3% stake in the company, while Sofinnova Capital has an 18.6% share.

French venture capital firm Sofinnova Partners joined US-based Sofinnova Ventures in a CHF 47.1m funding round in April 2013. The funding was split equally between the two investors, with Sofinnova Partners committing capital from its seventh fund.

In 2008, AGF Private Equity, ZKB Pharma Vision Fund, Lacuna Apo Biotech Fund and an industrial company injected approximately €7.4m into the firm.

Founded in 2003 and headquartered in Zug, Auris is a biotech dedicated to cochlear disorders. It is currently developing treatment for acute inner ear tinnitus and acute inner ear hearing loss, as well as pursuing early-stage research and development projects.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • DACH
  • Healthcare
  • Exits
  • IPO
  • Partial sale
  • Switzerland
  • Sofinnova Partners
  • Sofinnova
  • IDInvest Partners (AGF Private Equity)

More on DACH

Dataciders sponsor Auctus mulls sale via Houlihan Lokey
Dataciders sponsor Auctus mulls sale via Houlihan Lokey

German GP first acquired the local IT services group in May 2019 via Auctus V, a 2019-vintage

  • DACH
  • 16 August 2023
Bregal eyes local deal origination with new Swiss office
Bregal eyes local deal origination with new Swiss office

GP's third fund is completing its investment period, with fourth fund registered

  • DACH
  • 04 August 2023
Newly launched Utopia Capital aims to deploy EUR 10m-plus by 2028
Newly launched Utopia Capital aims to deploy EUR 10m-plus by 2028

Angel investor Christian Schroeder's new investment vehicle will support early-stage tech companies addressing humanitarian issues

  • DACH
  • 26 April 2023
Germany's DFL to collect NBOs for EUR 3bn media rights stake
Germany's DFL to collect NBOs for EUR 3bn media rights stake

Large-cap sponsors including Advent, Blackstone, Bridgepoint, CVC, EQT and KKR expected to bid today

  • DACH
  • 24 April 2023

Latest News

Partners Group to release IMs for Civica sale in mid-September
  • Exits
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
  • Investments
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • 01 September 2023
Redalpine expands leadership team amid CHF 1bn-plus fundraise
  • Venture
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • 31 August 2023
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • 31 August 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013